Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 41 - 50 of 84 opportunities
Long anticipated second-line therapies are available for prostate cancer patients following the failure of classical androgen deprivation therapy. However, there are no biomarkers available to predict which of these hormonal agents should be prescribed and which patients are most likely to respond i...
The trypanosomatid parasitic diseases of Animal and Human African Trypanosomiasis (AAT and HAT) are the most serious livestock and human diseases on the African continent.
Researchers at the University of Glasgow have developed auto-fluorescence imaging to be incorporated into wireless devices for gastrointestinal diagnosis . The technology will significantly increase the diagnostic modality of these types of pill cameras, leading to improved patient outcomes.
The University of Glasgow is offering an exciting new model for the evaluation of new treatments for Parkinsons disease
The University of Glasgow has developed a (Ad-hTR-NTR) which has been extensively tested on Ovarian cancer cells.
Inappropriate activation of the complement cascade is a significant cause of damage to implanted medical devices and stents. This polypeptide (TCP) that enhances the activity and protective properties of Factor H, a key regulator of the complement system. Surfaces coated with TCP molecules can prote...
This cattle‐specific vaccine delivery system can readily deliver and express antigens against a range of diseases that affect cattle, offering the potential to provide long term immunity and protection. It can also be used to deliver therapeutic proteins to improve productivity in cattle.
This luminance control technology characterises Electronic Visual Displays (EVDs) to accurately replicate a set of predetermined luminance levels across the entire display to meet light sensitivity requirements for vision assessment testing and vision-based research.
This app contains information on around 4,000 items of food and 12,000 portion sizes based on the complete food database published by the Food Standard Agency. This innovative application allows both a large number and cross section of the population, many of whom may be at risk of developing chroni...
A range of organopalladium catalysts suited to palladium catalysed carbonylation reactions in organic synthesis of esters from benzyl halides. Patent cover for the has lasped and these organometallic complexes are now offered for free use within the chemistry sector.